Back

Effect of pre-procedural blood pressure on one-year cardiovascular events after percutaneous coronary intervention in patients with acute myocardial infarction

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Predictors of outcome in acute coronary syndromes Acute Myocardial Ischaemia ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Viroj Muangsillapasart

Chulabhorn hospital, Bangkok (Thailand)

6 More presentations in this session

Presentation thumbnail
Secreted GRP78 attenuates endothelial inflammation and predicts outcome in coronary artery disease
Miss E. Repges (Bonn, DE)
Abstract Slides Video
Presentation thumbnail
Hs-CRP modifies the impact of stress hyperglycemia ratio on long-term outcomes in patients with acute coronary syndrome
Miss K. Zhang (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Ankle brachial index,a non invasive tool predicts cardiovascular events after acute myocardial infarction:a 3 year follow -up study
Mr A. Sakalidis (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Prognostic role of inflammatory status in type 2 myocardial infarction
Doctor L. Bavuso (Bologna, IT)
Abstract Slides Video
Presentation thumbnail
Prognostic significance of plasma molecular lipid species in coronary artery disease patients: A prospective cohort study
Doctor J. Veiga-Fernandes Mira (Rotterdam, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Predictors of outcome in acute coronary syndromes

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Association of cumulative systolic blood pressure load with cardiovascular events in patients undergoing percutaneous coronary intervention
thumbnail
Congress Presentation
The impact of blood pressure guidelines on the cardiovascular event risk in Japanese patients with coronary artery disease in a real-world database using a multimodal data acquisition system
thumbnail
Congress Presentation
Sacubitril/valsartan in heart failure with reduced ejection fraction patients: real world experience on hypotension, titration and drug combination

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources